SAM; Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for SAM; Johannes.The latest application filed is for "novel icos antibodies and tumor-targeted antigen binding molecules comprising them".

Company Profile

10.2.14

SAM; Johannes - Baden DE
SAM; Johannes - Schlieren CH
Sam; Johannes - Muenchen DE
Sam; Johannes - Freising DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Icos Antibodies And Tumor-targeted Antigen Binding Molecules Comprising Them App 20220098305 - DENGL; Stefan ; et al.	2022-03-31
Bispecific Antigen Binding Molecules Targeting Ox40 And Fap App 20220025046 - AMANN; Maria ; et al.	2022-01-27
Antibodies binding to HLA-A2/WT1 Grant 11,192,957 - Benz , et al. December 7, 2	2021-12-07
Therapeutic Combination Of 4-1 Bb Agonists With Anti-cd20 Antibodies App 20210163617 - FERRARA KOLLER; Claudia ; et al.	2021-06-03
Combination Therapy With Targeted 4-1bb (cd137) Agonists App 20210095002 - CLAUS; Christina ; et al.	2021-04-01
Combination therapy with targeted OX40 agonists App 20200392237 - BACAC; Marina ; et al.	2020-12-17
Methods Of Treating Cea-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-cea/anti-cd3 Bispecific Antibodies App 20200376119 - BACAC; Marina ; et al.	2020-12-03
Combination Therapy Of Anti-cd20/anti-cd3 Bispecific Antibodies And 4-1bb (cd137) Agonists App 20200325238 - BACAC; Marina ; et al.	2020-10-15
Combination Therapy Of Tumor Targeted Icos Agonists With T-cell Bispecific Molecules App 20200306373 - BACAC; Marina ; et al.	2020-10-01
Tumor-targeted Agonistic Cd28 Antigen Binding Molecules App 20200199234 - GEORGES; Guy ; et al.	2020-06-25
Type Ii Anti-cd20 Antibody And Anti-cd20/cd3 Bispecific Antibody For Treatment Of Cancer App 20200172627 - BACAC; Marina ; et al.	2020-06-04
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies Grant 10,596,257 - Bacac , et al.	2020-03-24
Antibodies binding To HLA-A2/WT1 App 20190248916 - Benz; Joerg ; et al.	2019-08-15
Methods Of Treating Cea-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-cea/anti-cd3 Bispecific Antibodies App 20180000931 - Bacac; Marina ; et al.	2018-01-04
Vivo Tumor Vasculature Imaging App 20120226119 - Dobosz; Michael ; et al.	2012-09-06
Yeast Platform Construction And Screening Methods App 20100081699 - Roca; Christophe Francois Aime ; et al.	2010-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.